DXCM · 10-Q · 2026Q3 · Full report

Revenue Performance and Mix

DEXCOM INC · 2026-10-29 · Importance 32 · Surprise 40 · Contradicted

Revenue for the three months ended September 30, 2026 rose 11% year over year to $1,344.5 million, while nine-month revenue increased 13% to $3,844.8 million. Nine-month U.S. revenue grew from $2,443.4 million to $2,735.5 million, and International revenue grew from $959.0 million to $1,109.3 million. Distributor revenue was $3,260.7 million for the nine months, versus $584.1 million through Direct channels; sensor volume growth drove revenue, while favorable revenue per customer from payor mix and utilization was partly offset by channel and product mix and rebate eligibility.

Key facts

• Dexcom reported third-quarter 2026 revenue of $1.34 billion, up 11% from the same period in 2025. source
• Nine-month 2026 revenue was $3,844.8 million, compared with $3,402.4 million in the first nine months of 2025, an increase of $442.4 million. source
• Nine-month 2026 revenue growth was driven by disposable-sensor sales volume and worldwide customer-base growth, favorable revenue per customer from payor mix and utilization, partly offset by channel and product mix and rebate eligibility. source
• Nine-month 2026 revenue growth also reflected favorable revenue per customer from payor mix and utilization, partly offset by channel and product mix and rebate eligibility. source
• Dexcom expects its revenue to fluctuate quarter to quarter. source

Impact estimates